Istanbul Rumeli University
Istanbul, Turkey (Türkiye)
NCT Number: NCT07253766
The goal of this clinical trial is to learn if kinesiologic taping works to treat individuals with Rheumatoid Arthritis.
The main questions it aim to answer:
* Is kinesiologic taping applied to the knee joint an effective treatment for pain, mobility, and kinesiophobia in individuals diagnosed with rheumatoid arthritis? * Which is more effective? Kinesiologic taping or non-therapeutic sham taping? Which is better for pain, functional capacity, kinesiophobia and disease activity? Researchers will compare kinesiologic taping and non-therapeutic sham taping . Patients will be randomly divided into groups. The first group of patients was treated with sham taping, and the application period was applied consecutively for 4 weeks, with a minimum interval of 3 days and a maximum interval of 5 days. Group 2 patients underwent kinesiological taping, with the application period ranging from 3 to 5 days per week for 4 consecutive weeks.
Looking for future studies?
Notify Me45 year–60 year
All sexes
Interventional
Not applicable
Istanbul, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The taping will be applied to the knee joint for 4 weeks.
The non-therapeutic taping will be applied to the knee joint for 4 weeks.
Time frame: Four Weeks
A Visual Analog scale(VAS) was used to assess pain intensity. Participants were asked to rate their perceived pain on a 10-cm horizontal line, where 0 cm indicates "no pain" and 10 cm indicates "worst pain imaginable." The participants marked a point on the line that best represented their pain intensity at rest and during activity. The distance (in centimeters) from the "no pain" end to the participant's mark was measured and recorded as the VAS score.
Time frame: Four Weeks
Kinesiophobia was assessed using the Tampa Scale for Kinesiophobia (TSK), a self-report questionnaire designed to measure fear of movement or re-injury. The scale consists of 17 items, each rated on a 4-point Likert scale ranging from 1 ("strongly disagree") to 4 ("strongly agree"). Higher scores indicate a greater degree of kinesiophobia, with a total score range between 17 and 68 points.
Time frame: Four weeks
Functional mobility was assessed using the Timed Up and Go (TUG) test, a simple and reliable measure of dynamic balance and mobility. Participants were instructed to rise from a standard chair, walk three meters, turn around, walk back, and sit down at their normal walking speed. The time taken to complete the task was measured in seconds using a stopwatch. Shorter completion times indicate better functional mobility.
Time frame: Four weeks
Disease activity was evaluated using the Disease Activity Score-28 (DAS28), which incorporates the number of tender and swollen joints (out of 28), the erythrocyte sedimentation rate (ESR), and the patient's global health assessment (GH) on a 100-mm Visual Analog Scale. The DAS28 score was calculated according to the standard formula, with values below 2.6 indicating remission, 2.6-3.2 low disease activity, 3.2-5.1 moderate activity, and above 5.1 high disease activity. This index is widely used to monitor disease progression and treatment response in patients with rheumatoid arthritis.
Istanbul Rumeli University
Other
The Effectiveness of Kinesiologic Taping in Patients With Knee Rheumatoid Arthritis in Terms of Pain, Function, and Kinesiophobia: A Randomised Controlled Trial
Acronym: Taping
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05877937
Anxiety, Anxiety Disorders
Eskişehir, Turkey (Türkiye)
View Trial DetailsNCT04246827
Arthritis, Arthritis, Rheumatoid
Durham, North Carolina, United States
View Trial DetailsNCT00979719
Arthritis, Arthritis, Rheumatoid
Berlin, State of Berlin, Germany
View Trial DetailsNCT06426316
Arthritis, Arthritis, Rheumatoid
Clermont-Ferrand, AURA, France
View Trial Details